Highlights and Quick Summary
- Non-current Revenue (Deferred) for the quarter ending September 30, 2022 was $0 (a NaN% decrease compared to previous quarter)
- Year-over-year quarterly Non-current Revenue (Deferred) decreased by -100.0%
- Annual Non-current Revenue (Deferred) for 2021 was $28.2 Million (a 124.31% increase from previous year)
- Annual Non-current Revenue (Deferred) for 2020 was $12.6 Million (a 1549.41% increase from previous year)
- Annual Non-current Revenue (Deferred) for 2019 was $763 Thousand (a 12616.67% increase from previous year)
Visit stockrow.com/BCEL
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Non-current Revenue (Deferred) of Atreca, Inc.
Most recent Non-current Revenue (Deferred)of BCEL including historical data for past 10 years.Interactive Chart of Non-current Revenue (Deferred) of Atreca, Inc.
Atreca, Inc. Non-current Revenue (Deferred) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $0.0 | $0.0 | $0.0 | – |
| 2021 | $28.23 | $28.68 | $27.93 | $21.65 | $28.23 |
| 2020 | $12.59 | $4.62 | $2.89 | $1.43 | $12.59 |
| 2019 | $0.76 | $0.12 | $0.02 | $0.0 | $0.76 |
| 2018 | $0.01 | $0.0 | $0.0 | – | $0.01 |
Business Profile of Atreca, Inc.
Sector: Healthcare
Industry: Biotechnology